Vierhapper H, Heinze G, Gessl A, Exner M
Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna, Vienna, Austria.
Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):415-20. doi: 10.1055/s-2003-44288.
Glucose tolerance and the behaviour of cortisol during an oral glucose tolerance test (OGTT) was investigated in 126 patients with adrenal "incidentalomas" (age: > 45 years) and in 129 age-matched controls. Impaired glucose tolerance (IGT) was found to be more common (p < 0.02) among patients with adrenal incidentalomas. Subdividing these patients by their body weight it was found that 29% (controls: 25%) of those with normal body weight (BMI 20 - 25 kg/m2) had IGT/DM. In overweight (BMI 25 - 30 kg/m2) and obese patients (BMI 30 - 40 kg/m2) the share of IGT/DM was 32% (controls: 19%) and 66% (controls 42%), respectively. The prevalence of a "paradoxical" rise in serum cortisol concentrations during the OGTT was slightly higher (p < 0.05) among patients with adrenal incidentaloma than among controls. Patients as well as controls with this abnormal behaviour of cortisol were characterized by lower basal serum cortisol concentrations (p < 0.01) but no association was seen with either the presence of IGT or with post-dexamethasone concentrations of serum cortisol. Thus both in patients with and without adrenal incidentalomas abnormal glucose tolerance is an age- and weight-dependent phenomenon unrelated to the post-prandial behaviour of serum cortisol concentrations.
对126例肾上腺“偶发瘤”患者(年龄>45岁)和129例年龄匹配的对照者进行了口服葡萄糖耐量试验(OGTT)期间的葡萄糖耐量和皮质醇行为研究。发现肾上腺偶发瘤患者中糖耐量受损(IGT)更为常见(p<0.02)。按体重对这些患者进行细分后发现,体重正常(BMI 20 - 25 kg/m²)的患者中有29%(对照者为25%)患有IGT/糖尿病。在超重(BMI 25 - 30 kg/m²)和肥胖患者(BMI 30 - 40 kg/m²)中,IGT/糖尿病的比例分别为32%(对照者为19%)和66%(对照者为42%)。OGTT期间血清皮质醇浓度出现“反常”升高的情况在肾上腺偶发瘤患者中的发生率略高于对照者(p<0.05)。具有这种皮质醇异常行为的患者和对照者的基础血清皮质醇浓度较低(p<0.01),但与IGT的存在或地塞米松后血清皮质醇浓度均无关联。因此,无论有无肾上腺偶发瘤,异常糖耐量都是一种与年龄和体重相关的现象,与血清皮质醇浓度的餐后行为无关。